توقعات سوق الجسيمات الشبيهة بالفيروسات في الشرق الأوسط وأفريقيا حتى عام 2028 - تأثير كوفيد-19 والتحليل الإقليمي حسب نوع المنتج (التهاب الكبد والسرطان/فيروس الورم الحليمي البشري ومرض غوشيه)، والمصدر (الخميرة، وخلايا الحشرات، والنباتات، وغيرها)، والتطبيق (اللقاحات والعلاجات)

1.            Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East & Africa Virus-like Particles Market – By Product Type

1.3.2        Middle East & Africa Virus-like Particles Market – By Source

1.3.3        Middle East & Africa Virus-like Particles Market – By Application

1.3.4        Middle East & Africa Virus-like Particles Market – By Country

2.           Middle East & Africa Virus-like Particles Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Middle East & Africa Virus-like Particles Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Experts Opinion

5.           Middle East & Africa Virus-like Particles Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Higher Prevalence of Infectious Viral Diseases

5.1.2        Fostering Role of Virus-Like Particles in Therapeutic Developments and Studies

5.2         Market Restraints

5.2.1        Existence of Alternative Technologies for Viral Vaccine Production

5.3         Market Opportunities

5.3.1        Increasing Potential Applications in Therapeutics and Diagnostics

5.4         Future Trends

5.4.1        Regular Demand for Innovative and Effective Products

5.5         Impact Analysis

6.           Middle East & Africa Virus-like Particles Market Analysis

6.1         Middle East & Africa Virus-like Particles Market Revenue Forecast and Analysis

7.           Middle East & Africa Virus-like Particles Market Analysis – by Product Type

7.1         Overview

7.2         Middle East & Africa Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

7.3         Hepatitis

7.3.1        Overview

7.3.2        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.4         Cancer/ Human Papillomavirus (HPV)

7.4.1        Overview

7.4.2        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.5         Gaucher Disease

7.5.1        Overview

7.5.2        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.           Middle East & Africa Virus-like Particles Market Analysis – By Source

8.1         Overview

8.2         Middle East & Africa Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

8.3         Yeast

8.3.1        Overview

8.3.2        Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.4         Plant

8.4.1        Overview

8.4.2        Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.5         Insect Cell

8.5.1        Overview

8.5.2        Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.           Middle East & Africa Virus-like Particles Market Analysis – By Application

9.1         Overview

9.2         Middle East & Africa Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

9.3         Vaccines

9.3.1        Overview

9.3.2        Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.4         Therapeutics

9.4.1        Overview

9.4.2        Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.        Middle East & Africa Virus-like Particles Market – Country Analysis

10.1      Overview

10.1.1     Middle East & Africa Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

10.1.1.1       UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.1.1.2       UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3       UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.4       UAE: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)

10.1.1.1.5       UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2       Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1       Overview

10.1.1.2.2       Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3       Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.4       Saudi Arabia: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)

10.1.1.2.5       Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3       South Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Overview

10.1.1.3.2       South Africa Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.4       South Africa: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)

10.1.1.3.5       South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4       Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1       Overview

10.1.1.4.2       Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3       Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.4       Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)

10.1.1.4.5       Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

11.        Impact Of COVID-19 Pandemic on Middle East & Africa Virus-like Particles Market

11.1      Impact Assessment of COVID-19 Pandemic

12.        Middle East & Africa Virus-like Particles Market–Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Merck & Co., Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      GlaxoSmithKline plc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Pfizer Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Sanofi

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Serum Institute of India Pvt. Ltd.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      BHARAT BIOTECH

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      LG Chem

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      VBI Vaccines Inc.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Middle East & Africa Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)

Table 2.             UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 3.             UAE Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 4.             UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 5.             Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 6.             Saudi Arabia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 7.             Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 8.             South Africa Virus-like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)

Table 9.             South Africa Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 10.          South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 11.          Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 12.          Rest of Middle East & Africa Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 13.          Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 14.          Organic Developments Done by Companies

Table 15.          Inorganic Developments Done by Companies

Table 16.          Glossary of Terms: Virus-like Particles Market

LIST OF FIGURES

Figure 1.           Middle East & Africa Virus-like particles Market Segmentation

Figure 2.           Middle East & Africa Virus-like particles Market Segmentation, By Country

Figure 3.           Middle East & Africa Virus-like Particles Market Overview

Figure 4.           Hepatitis Held the Largest Share of the Product Type Segment in Middle East & Africa Virus-like particles Market

Figure 5.           Saudi Arabia to Show Significant Growth during Forecast Period

Figure 6.           Middle East & Africa Virus-like Particles Market, Industry Landscape

Figure 7.           Middle East & Africa PEST Analysis

Figure 8.           Middle East & Africa Virus-like Particles Market: Impact Analysis of Drivers and Restraints

Figure 9.           Middle East & Africa Virus-like Particles Market– Revenue Forecast and Analysis to 2028

Figure 10.        Middle East & Africa Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

Figure 11.        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Middle East & Africa Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

Figure 15.        Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        Middle East & Africa Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

Figure 20.        Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Therapeutics: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        Middle East & Africa Virus-like Particles Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 23.        Middle East & Africa Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

Figure 24.        UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 26.        South Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Impact Of COVID-19 Pandemic in Middle East & African Countries

1. Merck & Co., Inc.                                                       
2. GlaxoSmithKline plc.                                                
3. Pfizer Inc.                                                                    
4. Sanofi                                                                         
5. Serum Institute of India Pvt. Ltd.                           
6. BHARAT BIOTECH                                                      
7. LG Chem                                                                     
8. VBI Vaccines Inc.                                                       

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa virus-like particles market.
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa virus-like particles market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the virus-like particles market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution